Amarin vows to challenge Vascepa patent ruling
04-09-2020
No fees award for PTAB proceedings, rules Fed Circuit
05-06-2020
Pavel Kapysh / Shutterstock.com
In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Amneal, Noven Pharmaceuticals, Minivelle, oestrogen patch, patent infringement, Chief Judge Leonard Stark, FDA
